Application Notes

Studying the interaction of the antibody-drug conjugate SYD985 with an anti-toxin antibody

Issue link: https://resources.nanotempertech.com/i/1050584

Contents of this Issue

Navigation

Page 2 of 2

3 Material and Methods Assay conditions Binding of labeled anti-toxin antibody to SYD977 and SYD985 in PBST buffer: Protein Labeling: 7 µM murine IgG2a anti-toxin antibody was labeled in PBS buffer using the Protein Labeling Kit RED-NHS (L001, NanoTemper Technologies, Germany). Sample Preparation: The concentration of the labeled anti-toxin antibody was kept constant at 1.5 nM. For the interaction analysis of SYD985 and SYD977 with the labeled anti-toxin antibody, SYD 977 or SYD985 was titrated in 1:1 dilutions. The highest concentration of SYD977 or SYD985 was 800 nM. All dilutions were performed in PBST- buffer (PBS + 0.05 % Tween-20). The samples were spun down 5 min at 4 °C, and then filled into MST Premium Coated capillaries (Cat# K005, NanoTemper Technologies, Germany). Binding of labeled anti-toxin antibody to SYD985 in human plasma containing buffer: SYD985 was titrated in 1:1 dilutions in PBST. Then, NT647-labeled anti-toxin antibody was added into 500 µl human plasma to a final concentration of 3 nM. 10 µl of NT647-labeled anti- toxin-containing human plasma was mixed with 10 µl SYD985 dilutions. The samples were spun down 5 min at 4 °C, and then filled into MST Premium Coated capillaries (Cat# K005, NanoTemper Technologies, Germany). Instrumentation: The measurements were conducted on a NanoTemper Monolith NT.115 instrument, at 10 % LED power and 80 % MST power. References 1. Chari, R.V.J., Miller, M.L., Widdison, W.C. . (2014) Antibody–Drug Conjugates: An Emerging Concept in Cancer Therapy. Angew. Chem. Int. Ed. 2014, 53, 3796 – 3827 2. Jerabek-Willemsen, M., André, T., Wanner, R., Roth, H. M., Duhr, S., Baaske, P., and Breitsprecher, D. (2014) MicroScale Thermophoresis: Interaction analysis and beyond. Journal of Molecular Structure Please note: This Application Note replaces NT-MO-025 because it contained erroneous information. © 2015 NanoTemper Technologies GmbH

Articles in this issue

view archives of Application Notes - Studying the interaction of the antibody-drug conjugate SYD985 with an anti-toxin antibody